Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
Status:
Completed
Trial end date:
2019-06-20
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the safety, tolerability, pharmacokinetics and
pharmacodynamics of ATI-50002 Topical Solution compared to vehicle in subjects with AU and
AT.